Generic placeholder image

Combinatorial Chemistry & High Throughput Screening


ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Research Article

Expression and Clinical Significance of PIEZO2 in Gastric Cancer

Author(s): Tong Liang* and Ming-Xu Da*

Volume 26, Issue 12, 2023

Published on: 14 March, 2023

Page: [2194 - 2200] Pages: 7

DOI: 10.2174/1386207326666230209140929

Price: $65


Objective: The aim of this research was to investigate the expression of PIEZO2 and its potential clinical significance in gastric cancer (GC).

Methods: In this study, we detected the protein expression levels of PIEZO2 in GC tissues and adjacent normal tissues by immunohistochemistry (IHC) and analysed the relationship between the protein expression levels of PIEZO2 and clinicopathological parameters of GC patients. Gene Expression Profiling Interactive Analysis (GEPIA) and Kaplan–Meier Plotter were used to verify the diagnostic and prognostic values of PIEZO2. Proteins interacting with PIEZO2 were predicted using the SRING database.

Results: Our results showed that the protein expression levels of PIEZO2 in GC tissues were lower than those in adjacent normal tissues (all P < 0.05), and the protein expression level of PIEZO2 was correlated with lymph node metastasis and TNM stage of GC patients (all P < 0.05). Aberrant overexpression of PIEZO2 was associated with poor prognosis of GC patients. Proteins such as VR1, TRPV1, LHFPL5, STOM, TRPA1 and STOML3 had obvious interactions with PIEZO2 (P = 0.00213).

Conclusion: In summary, our current study identified PIEZO2 as a promising target for early diagnosis and as a potential prognostic biomarker in GC patients.

Keywords: Gastric cancer, immunohistochemistry, diagnostic biomarker, prognosis, GEPIA, metastasis.

Graphical Abstract
Smyth, E.C.; Nilsson, M.; Grabsch, H.I.; van Grieken, N.C.T.; Lordick, F. Gastric cancer. Lancet, 2020, 396(10251), 635-648.
[] [PMID: 32861308]
Stocker, S.D.; Sved, A.F.; Andresen, M.C. Missing pieces of the Piezo1/Piezo2 baroreceptor hypothesis: an autonomic perspective. J. Neurophysiol., 2019, 122(3), 1207-1212.
[] [PMID: 31314636]
Del Rosario, J.S.; Yudin, Y.; Su, S.; Hartle, C.M.; Mirshahi, T.; Rohacs, T. Gi‐coupled receptor activation potentiates PIEZO2 currents via Gβγ. EMBO Rep., 2020, 21(5), e49124.
[] [PMID: 32227462]
Schneider, E.R.; Anderson, E.O.; Feketa, V.V.; Mastrotto, M.; Nikolaev, Y.A.; Gracheva, E.O.; Bagriantsev, S.N. A cross-species analysis reveals a general role for PIEZO2 in mechanosensory specialization of trigeminal ganglia from tactile specialist birds. Cell Rep., 2019, 26(8), 1979-1987.e3.
[] [PMID: 30784581]
Huang, Z.; Sun, Z.; Zhang, X.; Niu, K.; Wang, Y.; Zheng, J.; Li, H.; Liu, Y. Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration. Biosci. Rep., 2019, 39(3), BSR20181679.
[] [PMID: 30745454]
Lou, W.; Liu, J.; Ding, B.; Jin, L.; Xu, L.; Li, X.; Chen, J.; Fan, W. Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer. Aging (Albany NY), 2019, 11(9), 2628-2652.
[] [PMID: 31058608]
Etem, E.Ö.; Ceylan, G.G.; Özaydın, S.; Ceylan, C.; Özercan, I.; Kuloğlu, T. The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma. Adv. Clin. Exp. Med., 2018, 27(8), 1025-1031.
[] [PMID: 30010255]
Cheng, L.; Shen, Z.; Zhou, C. Promoter hypermethylation of PIEZO2 is a risk factor and potential clinical biomarker for laryngeal squamous cell carcinoma. Int. J. Clin. Exp. Pathol., 2017, 10(12), 11635-11643.
[PMID: 31966521]
Mering, C.; Huynen, M.; Jaeggi, D.; Schmidt, S.; Bork, P.; Snel, B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res., 2003, 31(1), 258-261.
[] [PMID: 12519996]
Zhang, Y.; Yao, J.; Feng, J.; Wang, S.; Yang, Z.; Huang, W.; Da, M. Relationship between PRRX1, circulating tumor cells, and clinicopathological parameter in patients with gastric cancer. J. BUON, 2020, 25(3), 1455-1462.
[PMID: 32862590]
Tang, Z.; Kang, B.; Li, C.; Chen, T.; Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res., 2019, 47(W1), W556-W560.
[] [PMID: 31114875]
Nagy, Á.; Lánczky, A.; Menyhárt, O.; Győrffy, B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci. Rep., 2018, 8(1), 9227.
[] [PMID: 29907753]
Bartha, Á. Győrffy, B. A web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int. J. Mol. Sci., 2021, 22(5), 2622.
[] [PMID: 33807717]
Yang, H.; Liu, C.; Zhou, R.M.; Yao, J.; Li, X.M.; Shen, Y.; Cheng, H.; Yuan, J.; Yan, B.; Jiang, Q. PIEZO2 protein: A novel regulator of tumor angiogenesis and hyperpermeability. Oncotarget, 2016, 7(28), 44630-44643.
[] [PMID: 27329839]
Zhou, T.; Gao, B.; Fan, Y.; Liu, Y.; Feng, S.; Cong, Q.; Zhang, X.; Zhou, Y.; Yadav, P.S.; Lin, J.; Wu, N.; Zhao, L.; Huang, D.; Zhou, S.; Su, P.; Yang, Y. Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin. eLife, 2020, 9, e52779.
[] [PMID: 32186512]
Ma, Y.; Zhao, Y.; Cai, Z.; Hao, X. Mutations in PIEZO2 contribute to Gordon syndrome, Marden Walker syndrome and distal arthrogryposis: A bioinformatics analysis of mechanisms. Exp. Ther. Med., 2019, 17(5), 3518-3524.
[] [PMID: 30988732]
Zapata-Aldana, E.; Al-Mobarak, S.B.; Karp, N.; Campbell, C. Distal arthrogryposis type 5 and PIEZO2 novel variant in a Canadian family. Am. J. Med. Genet. A., 2019, 179(6), 1034-1041.
[] [PMID: 30938034]

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy